Melanoma - Drug Pipeline Analysis and Market Forecast available through
12/23/2009 added a new report on "Melanoma - Drug Pipeline Analysis and Market Forecasts to 2015" which gives the future market associated with melanoma.

Online PR News – 23-December-2009 – – Melanoma - Drug Pipeline Analysis and Market Forecasts to 2015

This is an essential source of information and analysis on the global melanoma disease market. The report identifies the key trends shaping and driving the global melanoma disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global melanoma disease sector. ( )


The scope of the report includes:
- Annualized global melanoma market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes oxidative stress inducer targets, Bcl-2 receptor Mitotic Inhibitor, MAGE antigen, Immunomodulatory effects T-cell enhancer, anti-CTLA4, Peptide Viral vaccine, Peptide encapsulated vaccine, Combinations.
- Analysis of the current and future market competition in the global melanoma market. Key market players covered are Oncolytics Biotech., Bristol-Myers Squibb, Swedish Orphan International AB Bayer Schering Pharma AG, Genta Incorporated, Schering-Plough, GlaxoSmithKline and Abraxis BioScience.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with melanoma.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global melanoma disease market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global melanoma disease market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global melanoma disease market landscape? – Identify, understand and capitalize.

To know more and to buy a copy of your report feel free to visit :


Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter: